Karkatshringi

Pistacia chinensis ssp. integerrima
Karkatshringi (Pistacia chinensis ssp. integerrima), a significant tree in Ayurveda, is widely recognized for its horn-shaped galls. Traditionally, it's claimed to balance Vata, Pitta, and Kapha doshas. This herb is prevalent in various traditional practices for its supposed therapeutic properties, primarily utilizing its galls, bark, and leaves.
PLANT FAMILY
Anacardiaceae (Cashew/Sumac)
PARTS USED
Galls, Bark, Leaves
AYURVEDIC ACTION
Vata ↓, Pitta ↓, Kapha ↓
ACTIVE COMPOUNDS
Gallotannins (5-10%)

What is Karkatshringi?

Karkatshringi, scientifically known as Pistacia chinensis ssp. integerrima, is a species of tree belonging to the Anacardiaceae (Cashew/Sumac) family. This tree is notable for the distinctive horn-shaped galls that form on its leaves and branches, which are a primary part utilized in traditional practices.

Beyond the galls, the bark and leaves of the Karkatshringi tree are also used. Its properties are traditionally associated with balancing Vata, Pitta, and Kapha doshas, and it contains gallotannins as key active compounds.

Other Names of Karkatshringi

  • Crab's Claw
  • Kakrasingi
  • Pistacia Galls

Benefits of Karkatshringi

Heading

<h3> Absolute Contraindications of Karkatshringi </h3> <h4> Known allergy to pistachio/other Anacardiaceae plants (food or pollen allergy) [You are allergic to pistachios, mastic, mango, poison-ivy family]</h4> <ul> <li> 🧴</li> <li> Recommendation: Do not take Karkatshringi (any internal or topical form) if you have a known allergy to pistachio, mastic, mango or other Anacardiaceae family plants - talk to an allergist before any trial.</li> <li> Reasoning: Members of the Pistacia genus share allergenic proteins and pollen antigens; cross-reactivity and IgE-mediated responses have been documented across Pistacia species and related genera, meaning exposure can trigger respiratory or systemic allergic reactions in sensitized people.</li> <li> Scientific_Study_Title: Differences in IgE binding and skin responses to pollen extracts of four species of Pistacia.</li> <li> Scientific_Study_Authors: D. L. (authors listed in PubMed entry; see link for full list)</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/9140524/</li> <li> Scientific_Study_Excerpt: <p>Paraphrase of findings: The study compared pollen extracts from several Pistacia species and found measurable IgE binding and positive skin-test responses in a significant subset of atopic patients, demonstrating that Pistacia pollen contains clinically relevant allergens and that cross-reactivity exists among species - implying those with known Pistacia allergies may react to related species or products derived from them.</p> </li> </ul> <h4> Active or recent allergic contact dermatitis / severe eczema (skin exposure risk) [If your skin is inflamed or you had reactions to plant resins before]</h4> <ul> <li> 🔥</li> <li> Recommendation: Avoid topical or unprocessed use of Karkatshringi on inflamed or broken skin; if you have a history of contact dermatitis to plant resins, do not use it without patch testing under medical supervision.</li> <li> Reasoning: Plants in the Anacardiaceae family (including Pistacia species and related resins) are known to cause irritant or allergic contact dermatitis in susceptible people; topical exposure to plant oils or galls can provoke skin inflammation or delayed hypersensitivity.</li> <li> Scientific_Study_Title: Irritant potential and sub-acute dermal toxicity study of Pistacia lentiscus fatty oil as a topical traditional remedy.</li> <li> Scientific_Study_Authors: (authors listed in PubMed entry; see link for full list)</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/24146478/</li> <li> Scientific_Study_Excerpt: <p>Paraphrase of findings: In dermal testing on animals, topical Pistacia oil produced reversible irritant dermatitis at treated sites and was classified as slightly irritating; this supports caution when applying Pistacia-derived preparations to sensitive, inflamed, or broken skin in humans.</p> </li> </ul> <h4> Severe prior systemic hypersensitivity or anaphylaxis to Anacardiaceae products (history of anaphylaxis to marking nut / related substances)</h4> <ul> <li> 🚨</li> <li> Recommendation: Do not use Karkatshringi if you have ever experienced anaphylaxis to marking nut, cashew, mango or related Anacardiaceae substances; carry an epinephrine injector if prescribed and avoid exposure.</li> <li> Reasoning: Case reports document severe, systemic allergic reactions (including anaphylaxis) to certain Anacardiaceae products; cross-reactivity means exposure to related plant products can be dangerous for sensitized individuals.</li> <li> Scientific_Study_Title: Marking nut anaphylaxis - case report and discussion.</li> <li> Scientific_Study_Authors: (authors listed in PubMed case report; see link)</li> <li> Scientific_Study_Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967621/</li> <li> Scientific_Study_Excerpt: <p>Paraphrase of findings: The case report reviews instances where ingestion or topical use of members of the Anacardiaceae family caused severe allergic reactions, including one reported anaphylactic event linked to marking nut exposure; the authors highlight the need to avoid these botanicals in those with known severe allergies.</p> </li> </ul> <h3> Relative Contraindications of Karkatshringi </h3> <h4> Use with oral antidiabetic medications or if you have brittle/managed diabetes</h4> <ul> <li> ⚖️</li> <li> Recommendation: If you are taking antidiabetic drugs (especially agents that lower post-meal glucose), consult your physician before using Karkatshringi; glucose should be monitored closely while starting or stopping the herb.</li> <li> Reasoning: A bioactive molecule (pistagremic acid) isolated from the galls inhibits α-glucosidase in intestinal and yeast enzyme assays - an effect that can reduce postprandial glucose and theoretically add to pharmaceutical glucose-lowering, increasing risk of hypoglycaemia when combined.</li> <li> Scientific_Study_Title: Pistagremic acid, a glucosidase inhibitor from Pistacia integerrima.</li> <li> Scientific_Study_Authors: Ghias Uddin, Abdur Rauf, Abdulaziz M Al-Othman, Simona Collina, Muhammad Arfan, Gowhar Ali, Inamullah Khan.</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/23022534/</li> <li> Scientific_Study_Excerpt: <p>Paraphrase of findings: The authors isolated pistagremic acid and showed significant α-glucosidase inhibition in biochemical assays (IC50 values against yeast and rat intestinal enzymes), supporting a plausible blood-sugar lowering mechanism that could interact with conventional antidiabetic therapies.</p> </li> </ul> <h4> Pregnancy and breastfeeding (insufficient human safety data; presence of cytotoxic constituents in lab assays)</h4> <ul> <li> 🤰</li> <li> Recommendation: Avoid internal use of Karkatshringi during pregnancy and breastfeeding unless prescribed and supervised by a clinician experienced in botanical medicine; do not self-medicate in pregnancy.</li> <li> Reasoning: While some animal toxicity studies report no acute toxicity at certain doses, other laboratory assays find cytotoxic constituents in galls and reviews caution that many herbs lack reproductive safety data - together this produces insufficient evidence of safety in pregnancy or lactation.</li> <li> Scientific_Study_Title: Cytotoxic activity of extracts/fractions of various parts of Pistacia integerrima (brine-shrimp and in-vitro assays) and review on safety of herbal use in pregnancy.</li> <li> Scientific_Study_Authors: Ghias Uddin, Abdur Rauf, Bina Shaheen Siddiqui, Haroon Khan (cytotoxicity assay); plus pregnancy herbal-safety review authors in the cited review literature.</li> <li> Scientific_Study_Link: https://www.longdom.org/open-access/cytotoxic-activity-of-extractsfractions-of-various-parts-of-empistacia-integerrimaem-stewart-8611.html and https://pubmed.ncbi.nlm.nih.gov/33164294/</li> <li> Scientific_Study_Excerpt: <p>Paraphrase of findings: Brine-shrimp and other in-vitro assays show that Pistacia integerrima extracts (especially galls) contain fractions with notable cytotoxic activity; separate systematic reviews emphasize that many medicinal plants lack controlled reproductive safety data and therefore should be avoided in pregnancy unless proven safe.</p> </li> </ul>

Heading

<h4> Allergic skin reactions (rash, contact dermatitis, worsening eczema)</h4> <ul> <li> 🩹</li> <li> Side effect summary: Some people develop allergic or irritant skin reactions after touching Pistacia products or related resins; symptoms include redness, itching, blisters or eczema flare-ups.</li> <li> Recommendation: Stop use immediately if skin irritation appears; for severe reactions seek medical care. Avoid topical application if you have a history of plant resin allergies.</li> <li> Reasoning: Reports and patch-test data show Pistacia pollen and resins can sensitize people; topical Pistacia preparations produced reversible dermatitis in animal testing and case reports document human contact dermatitis to related products.</li> <li> Severity Level: Moderate</li> <li> Scientific_Study_Available: Yes</li> <li> Scientific_Study_Title: Marking nut anaphylaxis / Contact dermatitis from Pistacia-related resins and Mastisol-related reactions (case reports and patch-test studies).</li> <li> Scientific_Study_Authors: (see linked articles - case reports and contact dermatitis series referenced below)</li> <li> Scientific_Study_Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967621/ and https://pubmed.ncbi.nlm.nih.gov/24146478/</li> <li> Scientific_Study_Excerpt: <p>Paraphrase of findings: Case reports and clinical patch-test series document allergic contact dermatitis and, in rare instances, systemic allergic reactions after exposure to Anacardiaceae products; animal dermal studies with Pistacia oils produced reversible irritation, supporting real-world skin adverse events in susceptible individuals.</p> </li> </ul> <h4> Cytotoxicity at high concentrations (laboratory evidence)</h4> <ul> <li> ⚗️</li> <li> Side effect summary: Extracts of galls (and some other parts) show cytotoxic activity in laboratory assays; high, concentrated exposures could be harmful in theory.</li> <li> Recommendation: Avoid high-dose, unstandardized extracts; use clinically established formulations and doses, and consult a clinician for prolonged or high-dose use.</li> <li> Reasoning: Brine-shrimp lethality and other in-vitro cytotoxic screens found potent activity in polar fractions of galls, indicating presence of bioactive compounds that at high doses can damage cells in laboratory models.</li> <li> Severity Level: Moderate</li> <li> Scientific_Study_Available: Yes</li> <li> Scientific_Study_Title: Cytotoxic activity of extracts/fractions of various parts of Pistacia integerrima (brine-shrimp assay).</li> <li> Scientific_Study_Authors: Ghias Uddin, Abdur Rauf, Bina Shaheen Siddiqui, Haroon Khan (as reported in the cytotoxicity article).</li> <li> Scientific_Study_Link: https://www.longdom.org/open-access/cytotoxic-activity-of-extractsfractions-of-various-parts-of-empistacia-integerrimaem-stewart-8611.html</li> <li> Scientific_Study_Excerpt: <p>Paraphrase of findings: Multiple fractions of P. integerrima, particularly the galls, produced significant lethality in brine-shrimp assays - a standard preliminary test for cytotoxic constituents - implying that some components are cell-active and warrant dose caution.</p> </li> </ul> <h4> Potential hypoglycaemia or additive blood-sugar lowering when used with antidiabetic drugs</h4> <ul> <li> 🩸</li> <li> Side effect summary: Because an isolated constituent (pistagremic acid) inhibits intestinal α-glucosidase, combining the herb with antidiabetic medicines could lead to lower post-meal blood sugar than expected.</li> <li> Recommendation: If you have diabetes or take glucose-lowering drugs, discuss with your prescriber and monitor blood sugar closely when starting or stopping Karkatshringi.</li> <li> Reasoning: Experimental enzyme inhibition (α-glucosidase) provides a direct biochemical mechanism for reducing postprandial glucose; combined effects with pharmaceuticals require clinical monitoring to avoid hypoglycaemia.</li> <li> Severity Level: Moderate</li> <li> Scientific_Study_Available: Yes</li> <li> Scientific_Study_Title: Pistagremic acid, a glucosidase inhibitor from Pistacia integerrima.</li> <li> Scientific_Study_Authors: Ghias Uddin, Abdur Rauf, Abdulaziz M Al-Othman, Simona Collina, Muhammad Arfan, Gowhar Ali, Inamullah Khan.</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/23022534/</li> <li> Scientific_Study_Excerpt: <p>Paraphrase of findings: The authors isolated pistagremic acid and demonstrated potent inhibition of α-glucosidase (rat intestinal and yeast enzymes), supporting a plausible glucose-blunting effect that could interact additively with antidiabetic drugs in clinical settings.</p> </li> </ul>

Heading

<h4> Antidiabetic medications (sulfonylureas, insulin, metformin, acarbose and others that lower blood glucose)</h4> <ul> <li> Interaction_Details: Karkatshringi contains pistagremic acid which inhibits α-glucosidase in gut enzyme assays - this may reduce post-meal glucose and add to the effect of prescription glucose-lowering medicines, increasing hypoglycaemia risk.</li> <li> Severity: Moderate</li> <li> Recommendation: Consult your prescribing clinician before combining; monitor blood glucose closely and be prepared to adjust medication under medical guidance.</li> <li> Scientific_Study_Available: Yes</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/23022534/</li> <li> Scientific_Study_Title: Pistagremic acid, a glucosidase inhibitor from Pistacia integerrima.</li> <li> Scientfic_Study_Authors: Ghias Uddin, Abdur Rauf, Abdulaziz M Al-Othman, Simona Collina, Muhammad Arfan, Gowhar Ali, Inamullah Khan.</li> <li> Scientific_Study_Excerpt: <p>Paraphrase of findings: In biochemical and intestinal enzyme assays the isolated pistagremic acid showed significant α-glucosidase inhibition (IC50s in the micromolar range against yeast and rat intestinal enzymes), indicating a mechanism that can lower postprandial glucose and may potentiate antidiabetic drugs.</p> </li> </ul> <h4> Xanthine oxidase inhibitors / gout drugs (e.g., allopurinol) - (possible additive uric-acid lowering)</h4> <ul> <li> Interaction_Details: Extracts of P. integerrima show xanthine-oxidase inhibitory activity in vitro and produced uric-acid lowering in animal models; when combined with pharmaceutical xanthine oxidase inhibitors there may be additive effects on uric acid metabolism.</li> <li> Severity: Mild</li> <li> Recommendation: If you are on urate-lowering therapy, inform your clinician before starting Karkatshringi - your provider may wish to monitor uric acid and adjust therapy if needed.</li> <li> Scientific_Study_Available: Yes</li> <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/18420362/</li> <li> Scientific_Study_Title: Pharmacological basis for use of Pistacia integerrima leaves in hyperuricemia and gout.</li> <li> Scientfic_Study_Authors: Naseem Saud Ahmad, Muhammad Farman, Muzammil Hasan Najmi, Kouser Bashir Mian, Aurangzeb Hasan.</li> <li> Scientific_Study_Excerpt: <p>Paraphrase of findings: Ethyl acetate and butanol fractions of Pistacia integerrima showed xanthine oxidase inhibitory activity in vitro and dose-dependent uric-acid lowering in hyperuricemic mice - supporting a biochemical basis for urate reduction that could add to pharmaceutical xanthine oxidase inhibitors.</p> </li> </ul>